Faheema Hasan: History to management of primary and secondary HLH

Faheema Hasan, Assistant Professor and Hemato-Oncology at UIMS, shared an article by Jan-Inge Henter, et al. on X:

“Beautiful review of HLH on NEJM from history to management of primary and secondary HLH In the revised HLH 2024 criteria, natural killer cell activity is removed as a criterion, a huge relief and 5/7 criteria to be met for diagnosis.”